TRIMEL BIOPHARMA SRL has a total of 27 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Mexico, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and computer technology are ACERUS BIOPHARMA INC, EDGE THERAPEUTICS and HALE BIOPHARMA VENTURES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Mexico | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 3 | |
#4 | Israel | 3 | |
#5 | Republic of Korea | 3 | |
#6 | United States | 3 | |
#7 | Brazil | 2 | |
#8 | South Africa | 2 | |
#9 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Maes Paul Jose Pierre Marie | 16 |
#2 | Kreppner Wayne | 16 |
#3 | Oberegger Werner | 14 |
#4 | Fogarty Siobhan | 13 |
#5 | Wayne Kreppner | 5 |
#6 | Siobhan Fogarty | 5 |
#7 | Paul José Pierre Marie Maes | 5 |
#8 | Werner Oberegger | 4 |
#9 | Maes Paul José Pierre Marie | 3 |
#10 | Aberegger Werner | 2 |
Publication | Filing date | Title |
---|---|---|
WO2014080282A2 | One- and two-point titration methods to determine daily treatment regimens to treat hypogonadism or testosterone deficiency | |
US2015290217A1 | Male testosterone titration methods, male intranasal testosterone bio-adhesive gel formulations and use thereof for treating hypogonadism and trt | |
US2015297733A1 | Controlled release topical testosterone formulations and methods | |
WO2014083432A2 | Female intranasal testosterone gel for treating anorgasmia | |
BR112013029335A2 | testosterone gel formulations of lower intranasal dosage intensity and use thereof for the treatment of anorgasmia or hypoactive sexual desire disorder | |
CA2835911A1 | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder | |
MX2013013236A | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder. |